Novo Nordisk rises after application
Photo: Richard Drew/AP

Novo Nordisk rises after application

Danish pharmaceutical giant Novo Nordisk rose 4.7 percent on the Copenhagen Stock Exchange after the company announced that it had submitted a supplementary application to the US FDA.

The pharmaceutical giant has applied for permission for a higher dose of the weight loss drug Wegovy in injectable form, they announced in a press release.

The application is expected to take 1 to 2 months for the authority to process. The stock is still down 49 percent this year.

AuthorTT News AgencyEnglish edition by Sweden Herald, adapted for our readers
Was this useful?

What do you think?

Keep readingmore from Business

All